These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12691055)

  • 1. Effects of exercise on plasma lipoproteins.
    Mascitelli L; Pezzetta F
    N Engl J Med; 2003 Apr; 348(15):1494-6; author reply 1494-6. PubMed ID: 12691055
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update.
    Genest J; Frohlich J; Fodor G; McPherson R;
    CMAJ; 2003 Oct; 169(9):921-4. PubMed ID: 14581310
    [No Abstract]   [Full Text] [Related]  

  • 3. I have elevated levels of C-reactive protein. How does that affect my risk of developing heart disease?
    Gibbons E
    Health News; 2002 Nov; 8(11):12. PubMed ID: 12523257
    [No Abstract]   [Full Text] [Related]  

  • 4. [JUPITER study (2). For now no reason to give statins to more people].
    Koopmans RP
    Ned Tijdschr Geneeskd; 2009 Feb; 153(6):218-9. PubMed ID: 19271439
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of exercise on plasma lipoproteins.
    Schmidt-Trucksäss A
    N Engl J Med; 2003 Apr; 348(15):1494-6; author reply 1494-6. PubMed ID: 12691054
    [No Abstract]   [Full Text] [Related]  

  • 6. [C-reactive protein potential risk factor for cardiovascular disease].
    Tornvall P; Pernow J; Hansson LO
    Lakartidningen; 2003 Aug; 100(35):2691-3. PubMed ID: 14531129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of exercise on plasma lipoproteins.
    Sharma AM
    N Engl J Med; 2003 Apr; 348(15):1494-6; author reply 1494-6. PubMed ID: 12686709
    [No Abstract]   [Full Text] [Related]  

  • 8. Exercise to reduce cardiovascular risk--how much is enough?
    Tall AR
    N Engl J Med; 2002 Nov; 347(19):1522-4. PubMed ID: 12421896
    [No Abstract]   [Full Text] [Related]  

  • 9. Alterations of atherogenic low-density lipoproteins and serum fatty acids after 12 week moderate exercise training in sedentary Thai women.
    Sittiwicheanwong R; Ariyapitipun T; Gulsatitporn S; Nopponpunth V; Abeywardena M; Dahlan W
    Asia Pac J Clin Nutr; 2007; 16(4):602-8. PubMed ID: 18042518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JUPITER study highlights C-reactive protein as a cardiac risk factor.
    Cardiovasc J Afr; 2009; 20(2):146. PubMed ID: 19421655
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of exercise training on 5 inflammatory markers associated with cardiovascular risk.
    Hammett CJ; Prapavessis H; Baldi JC; Varo N; Schoenbeck U; Ameratunga R; French JK; White HD; Stewart RA
    Am Heart J; 2006 Feb; 151(2):367.e7-367.e16. PubMed ID: 16442901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosuvastatin in patients with elevated C-reactive protein.
    Jenny-Avital ER
    N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271275
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluvastatin blunts the effect of a high-fat meal on plasma triglyceride and high-sensitivity C-reactive protein concentrations in patients at high risk for cardiovascular events.
    Liu L; Zhao SP; Hu M; Li JX
    Coron Artery Dis; 2007 Sep; 18(6):489-93. PubMed ID: 17700222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of high-sensitivity C-reactive protein to exercise training in an at-risk population.
    Huffman KM; Samsa GP; Slentz CA; Duscha BD; Johnson JL; Bales CW; Tanner CJ; Houmard JA; Kraus WE
    Am Heart J; 2006 Oct; 152(4):793-800. PubMed ID: 16996860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of exercise training on C-reactive protein in postmenopausal breast cancer survivors: a randomized controlled trial.
    Fairey AS; Courneya KS; Field CJ; Bell GJ; Jones LW; Martin BS; Mackey JR
    Brain Behav Immun; 2005 Sep; 19(5):381-8. PubMed ID: 15922556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How I treat diabetic dyslipemia in the framework of preventing cardiovascular pathology].
    Berthezène F; Bernard S
    Journ Annu Diabetol Hotel Dieu; 1997; ():237-44. PubMed ID: 9296979
    [No Abstract]   [Full Text] [Related]  

  • 17. CRP as a marker for cardiovascular risk.
    Savill P
    Practitioner; 2008 Dec; 252(1713):4. PubMed ID: 19192697
    [No Abstract]   [Full Text] [Related]  

  • 18. [Statin cuts cardiovascular risk in half].
    Einecke D
    MMW Fortschr Med; 2008 Dec; 150(49-50):12-3. PubMed ID: 19133364
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperlipidaemia and cardiovascular disease.
    Le NA
    Curr Opin Lipidol; 1999 Apr; 10(2):187-9. PubMed ID: 10327289
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardiovascular prevention: recommendations for approaching the vascular risk associated with dyslipidemia].
    da Silva PM; Silva JM; Gil VM;
    Rev Port Cardiol; 2002 Oct; 21(10):1201-9. PubMed ID: 12522982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.